Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$3.79 - $9.78 $1.87 Million - $4.83 Million
-494,297 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$3.47 - $4.52 $414,553 - $539,995
-119,468 Reduced 19.46%
494,297 $1.86 Million
Q3 2020

Nov 16, 2020

BUY
$3.55 - $9.99 $2.18 Million - $6.13 Million
613,765 New
613,765 $2.18 Million

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.